Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Thymic mesenchymal cells have unique gene expression that supports their specific functions in the thymus.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Certain immune cells help hair growth by regulating iron in the skin.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Alopecia areata is an autoimmune disease that targets hair follicles.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Skin bacteria can help wound healing by activating certain immune cells.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Blocking LFA-1 prevents hair loss in mice.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.